Epstein-Barr Virus-Associated Malignancies

References

• Ablashi D. V. Epstein-Barr virus markers in the diagnosis and prognosis of nasopharyngeal carcinoma, in press
   Google Scholar
• Ablashi D. V., Levene P. H., Papost Pearson G. R., Koffaridis S. D. First international symposium on Epstein-Barr virus and associated malignant disease. Cancer 1985; 45: 3981
   Web of Science ®Google Scholar
• Abo W., Takada K., Kamada M., et al. Evolution of infectious mononucleosis into Epstein-Barr virus carrying monoclonal malignant lymphoma. Lancet 1982; 1272
   PubMed Web of Science ®Google Scholar
• Andersson-Anvret M., Forsby N., Klein G., Henle W. Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. Int. J. Cancer 1977; 20: 486
   PubMed Web of Science ®Google Scholar
• Andiman W. A. The Epstein-Barr virus and EB virus infections in childhood. J. Pediatr. 1979; 95: 171
   PubMed Web of Science ®Google Scholar
• Andiman W., Gradoville L., Heston L., et al. Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases. J. Infect. Dis. 1983; 148(6)967
   PubMed Web of Science ®Google Scholar
• Aronson M. D., Komaroff A. L., Pass T. M. Heterophil antibody in adults with sore throat. Ann. Intern Med. 1982; 96(4)505
   PubMed Web of Science ®Google Scholar
• Baker S. R., McClatchey K. D. Carcinoma of the nasopharynx in childhood. Otolaryngol. Head Neck Surg. 1981; 89: 555
   PubMed Web of Science ®Google Scholar
• Bauer G., Hofler P., Simon M. Epstein-Barr virus induction by a serum factor. Characterization of the purified factor and the mechanism of its activation. J. Biol. Chem. 1982; 259(19)1141
   Google Scholar
• Ben-Bassat H., et al. Induction of Epstein-Barr virus nuclear antigen and DNA synthesis in a human epithelial cell line after Epstein-Barr virus infection. J. Virol. 1982; 41: 703
   PubMed Web of Science ®Google Scholar
• Berkel A. I., Henle W., Henle G., et al. Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia. Clin. Exp. Immunol. 1979; 35: 196
   PubMed Web of Science ®Google Scholar
• Biggar R. J., Henle G., Bocker J., et al. Primary Epstein-Barr infections in African infants. II. Clinical and serological observations during seroconversion. Int. J. Cancer 1978; 22: 244
   PubMed Web of Science ®Google Scholar
• Bird A. G., Britton J. S. The relationship between Epstein-Barr virus and lymphoma. Semin. Hematol. 1982; 19: 285
   PubMed Web of Science ®Google Scholar
• Birx D. L., Redfield R. R., Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS related disorders. N. Engl. J. Med. 1986; 314: 874
   PubMed Web of Science ®Google Scholar
• Booth K., Burkitt D. P., Baskett D. J., et al. Burkitt lymphoma in Papua, New Guinea. Br. J. Cancer 1967; 21: 657
   PubMed Web of Science ®Google Scholar
• Borzy M. S., Hong R., Horowitz S. D., et al. Fatal lymphoma after transplantation of cultured thymus in children with combined immunodeficiency disease. N. Engl. J. Med. 1969; 301: 565
   Google Scholar
• Boss L. P., Levine P. H., Hanes R. S. A cluster of young patients with Burkitt's lymphoma and nasopharyngeal carcinoma in central Texas. JAMA 1985; 253(19)2843
   PubMed Web of Science ®Google Scholar
• Boyd E. L., McClung J. E., Veltri R. W., Sprinkle P. M. Early antigen titers in pediatric patients with acute cervical lymphadenitis. Otolaryngol. Head Neck Surg. 1982; 90: 6
   PubMed Web of Science ®Google Scholar
• Brandtzaeg. Immune functions of human nasal mucosa and tonsils in health and disease. Immunology of the Lung and Upper Respiratory Tract, J. Bienenstoch. McGraw-Hill, New York, 19, 28
   Google Scholar
• Brewster F. E., Byron K. S., Sullivan J. L. Immunoregulation during acute infection with Epstein-Barr virus: dynamics of interferon and 2′, 5′-oligoadenylate synthetase activity. J. Infect. Dis. 1985; 151(6)1109
   PubMed Web of Science ®Google Scholar
• Brichacek B., Hirsch I., Sibl O., et al. Association of some supraglottic laryngeal carcinomas with EB virus. Int. J. Cancer 1983; 32: 193
   PubMed Web of Science ®Google Scholar
• Brichacek B., Suchankova I., Hirsch I., Sibl O., et al. Presence of Epstein-Barr virus DNA in tonsillar tissues. Acta Virol. 1981; 25: 361
   PubMed Web of Science ®Google Scholar
• Brichacek B., Hirsch I., Sibl O., et al. Presence of Epstein-Barr virus DNA in carcinomas of the palatine tonsil. J. Natl. Cancer Inst. 1984; 72: 809
   PubMedGoogle Scholar
• Burkitt D. A sarcoma involving the jaws in African children. Br. J. Surg. 1958; 46: 218
   PubMed Web of Science ®Google Scholar
• Cai W. M., Li Y. W., Wu B., et al. Serologic diagnosis of nasopharyngeal carcinoma. A double-bind study of four EB virus antibodies with evaluation by sequential discrimination. Int. J. Radiat. Oncol. Biol. Phys. 1983; 9: 1761
   Web of Science ®Google Scholar
• Calne R. Y., Rolles K., White D. J. G., et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979; 2: 1033
   PubMed Web of Science ®Google Scholar
• Calne R. Y., White D. J. G., Evans D. B., et al. Cyclosporin A in cadaveric organ transplantation. Br. Med. J. 1981; 282: 934
   PubMed Web of Science ®Google Scholar
• Calnek B. N., Hitchner S. B. Localization of viral antigen in chickens cofeetid with Marek's Disease Herpes virus. J. Natl. Cancer Inst. 1969; 43: 935
   PubMed Web of Science ®Google Scholar
• Carbone A., Micheau C. Pitfalls in microscopic diagnosis of undifferentiated carcinoma of nasopharyngeal type (lymphoepithelioma). Cancer 1982; 50: 1344
   PubMed Web of Science ®Google Scholar
• Carey T. E., Kimmel K. A., Schwartz D. R., Richter D. E., Baker S. R., Krause C. J. Antibodies to human squamous cell carcinoma. Otolaryngol. Head Neck Surg. 1983; 91: 4820
   Web of Science ®Google Scholar
• Chan S. H., Chew T. S. Lack of regression in Epstein-Barr virus infected leukocyte cultures of nasopharyngeal carcinoma patients. Lancet 1981; 2: 1353
   PubMed Web of Science ®Google Scholar
• Cheng Y. C., Chen J. Y., Glaser R., Henle W. Frequency and levels of antibodies to Epstein-Barr virus-specific DNAse are elevated in patients with nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. U.S.A. 1980; 77(10)6162
   PubMed Web of Science ®Google Scholar
• Colby B. M., Shaw J. E., Datta A. K., Pagano J. S. Replication of Epstein-Barr virus DNA in lymphoblastoid cells treated for extended periods with acyclovir. Am. J. Med. 1982; 73: 77
   PubMed Web of Science ®Google Scholar
• Crawford D. H., Thomas J. A., Janossy G., et al. Epstein-Barr virus nuclear antigen positive lymphoma after Cyclosporin A treatment in patient with renal allograft. Lancet 1980; 2: 1355
   Google Scholar
• Crawford D. H., Sweny P., Edwards J. M. B., et al. Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving Cyclosporin A. Lancet 1981; 1: 10
   PubMed Web of Science ®Google Scholar
• Crawford D. H., Iliescu V., Edwards A. J., Beverley P. C. L. Characterization of Epstein-Barr virus-specific memory T cells from peripheral blood of seropositive individuals. Br. J. Cancer 1983; 47: 681
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R. C., Crocel C. M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. U.S.A. 1982; 79: 7824
   PubMed Web of Science ®Google Scholar
• Desgranges C., Seigneurin J. M., Baccard M., Nejmi S. Cytomegalovirus isolations from cell cultures derived from Epstein-Barr virus-associated nasopharyngeal carcinoma. J. Natl. Cancer Inst. 1983; 71(1)39
   PubMedGoogle Scholar
• de-The G. Hypothesis: is Burkitt's lymphoma related to perinatal infection by Epstein-Barr virus?. Lancet 1977; 1: 335
   PubMed Web of Science ®Google Scholar
• de-The G., Gaser A., Day N. E., et al. Epidemiological evidence for a causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (London) 1978; 274: 756
   PubMed Web of Science ®Google Scholar
• Diehl V., Krause P., Hellriegel K. P., et al. Lymphoid cell lines: in vitro cell markers and tumorigenicity in nude mice. Immunological Diagnosis of Leukemias and Lymphomas, T. Thierfelder, H. Rodt, E. Theil. Springer-Verlag, Berlin 1977; 289
   Google Scholar
• Douglas E. C., Nagrath I. T., Lee E. C., Whang-Peng J. Cytogenetic studies in non-African Burkitt lymphoma. Blood 1980; 55: 148
   PubMed Web of Science ®Google Scholar
• Dwyer J. M. Anergy, the mysterious loss of immunological energy. Prog. Allergy 1984; 35: 1
   Google Scholar
• Ebbesen P., Melbye M., Levine P. H., Andersen H. K. Danish children in Greenland have high Epstein-Barr virus titers. Infect. Immun. 1983; 41: 418
   PubMed Web of Science ®Google Scholar
• Editorial. What we could do with an EBV vaccine?. Lancet 1981; 1: 759
   PubMed Web of Science ®Google Scholar
• Epstein M. A., Henle G., Achong B. G., et al. Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt's lymphoma. J. Exp. Med. 1965; 121: 761
   PubMed Web of Science ®Google Scholar
• Epstein M. A., Achong B. G., Barr Y. M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702
   PubMed Web of Science ®Google Scholar
• Epstein M. A., Achong B. G. The EB virus. Annu. Rev. Microbiol. 1973; 27: 413
   PubMed Web of Science ®Google Scholar
• The Epstein-Barr Virus, M. A. Epstein, B. G. Achong. Springer-Verlag, New York 1979
   Google Scholar
• Epstein M. A., Morgan A. J. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine. Clin. Exp. Immunol. 1983; 53: 257
   PubMed Web of Science ®Google Scholar
• Erikson J., ar-Rushdi A., Drwinga H., Nowell P., Croce C. M. Transcriptional activation of the translocated c-myc oncogene in Burkitt lymphoma. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 820
   PubMed Web of Science ®Google Scholar
• Falser N. The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathy. Arch. Otorhinolaryngol. 1984; 239: 15
   PubMedGoogle Scholar
• Fleisher G., Bolognese R. Persistent Epstein-Barr virus infection and pregnancy. J. Infect. Dis. 1983; 147(6)982
   PubMed Web of Science ®Google Scholar
• Furukawa M., Takimoto T., Morishita K., et al. The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma. Auris. Nasus. Larynx (Tokyo) 1983; 10: 43
   PubMedGoogle Scholar
• Gartner J. G., Seemayer T. A. New oncologic association for the Epstein-Barr virus. Am. J. Surg. Pathol. 1982; 6(5)471
   PubMed Web of Science ®Google Scholar
• Gatti R. A., Good R. A. Occurrence of malignancy in immunodeficiency diseases. Cancer 1971; 28: 89
   PubMed Web of Science ®Google Scholar
• Giffler R. F., Gillespie J. J., Ayala A. G., Newland J. R. Lymphoepithelioma in cervical lymph nodes of children and young adults. Am. J. Surg. Pathol. 1977; 1(4)293
   Web of Science ®Google Scholar
• Glaser R., Lang C. M., Lee K. J., Schuller D. E., Jacobs D., McQuattie C. Attempt to infect nonmalignant nasopharyngeal epithelial cells from humans and squirrel monkeys with Epstein-Barr virus. J. Natl. Cancer Inst. 1980; 64(5)1085
   PubMedGoogle Scholar
• Glaser R., Nonoyama M., Szymanowski R. J., Graham W. Human nasopharyngeal carcinomas positive for Epstein-Barr virus DNA in North America. J. Natl. Cancer Inst. 1980; 64(6)1317
   PubMedGoogle Scholar
• Gordon E. M., Berkowitz R. J., Strandjord S. E., et al. Burkitt lymphoma in a patient with classic hemophilia receiving factor VIII concentrates. J. Pediatr. 1983; 103(1)75
   PubMed Web of Science ®Google Scholar
• Grufferman S., Raab-Traub N., Borowitz M. J., Pagano J. S. Burkitt's and other lymphomas in adults exposed to a visitor from Africa. N. Engl. J. Med. 1985; 313: 1525
   PubMed Web of Science ®Google Scholar
• Greenspan J. S., Greenspan D., Lennette E. T., Abrams D. I., Conant M. A., Petersen V., Freese U. K. Replication of Epstein-Barr virus within the epithelial cells of oral “Hairy” leukoplakia, an AIDS-associated lesion. N. Engl. J. Med. 1985; 313: 1564
   PubMed Web of Science ®Google Scholar
• Hanto D. W., Frizzera G., Gail-Peczalska J., et al. The Epstein-Barr virus (EBV) in the pathogenesis of posttransplant lymphoma. Transplant. Proc. 1981; 13: 756
   PubMed Web of Science ®Google Scholar
• Hansen Hart J. P., Meldgaard J., Nordqvist J. The mummies of Qulakitsoq. Nat. Geo. 1985; 167: 191
   Google Scholar
• Heffner D. K. Problems in pediatric otorhinolaryngic pathology. IV. Epithelial and lymphoid tumors of the sinonasal tract and nasopharynx. Int. J. Pediatr. Otorhinolaryngol. 1983; 6: 219
   PubMed Web of Science ®Google Scholar
• Hellmann D., Cowan M. J., Ammann A. J. Chronic active Epstein-Barr virus infections in two immunodeficient patients. J. Pediatr. 1983; 103(4)585
   PubMed Web of Science ®Google Scholar
• Henle G., Henle W. Immunofluorescence, interference and complement fixation in the detection of the herpes-type virus in Burkitt tumor cell lines. Cancer Res. 1967; 27: 2442
   PubMed Web of Science ®Google Scholar
• Henle G., Henle W. Epstein-Barr virus specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer 1976; 17: 107
   Web of Science ®Google Scholar
• Henle W., Henle G. Epstein-Barr virus-related serology in Hodgkin's disease. Natl. Cancer Inst. Monogr. 1973; 36: 79
   PubMedGoogle Scholar
• Henle W., et al. The Epstein-Barr virus. Sci. Am. 1979; 241: 48
   PubMed Web of Science ®Google Scholar
• Henle W., Henle G. Epstein-Barr virus and human malignancies. Adv. Viral Oncol. 1985; 5: 201
   Google Scholar
• Hertel B. F., Rosai J., Dehner L. P., et al. Lymphoproliferative disorders in organ transplant recipients. Lab. Invest. 1977; 36: 340
   Web of Science ®Google Scholar
• Herberman R. B., Djeu J. Y., Kay D., Ortaldo J. R., Riccardi C., Bonnard G. D., Holden H. T., Fagnani R., Santoni A. S., Puccetti P. Natural killer cells: characteristics and regulation of activity. Immunol. Rev. 1979; 44: 43
   PubMed Web of Science ®Google Scholar
• Hochberg F. H., Miller G., Schooley R. T., Hirsch M. S., Feorino P., Henle W. Central nervous system lymphoma related to Epstein-Barr virus. J. Engl. J. Med. 1983; 309: 745
   PubMed Web of Science ®Google Scholar
• Hoover R., Fraumeni J. F. Risk of cancer in renal-transplant recipients. Lancet 1973; 2: 55
   PubMed Web of Science ®Google Scholar
• Horwitz C. A., et al. Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex. Am. J. Med. 1975; 58: 330
   PubMed Web of Science ®Google Scholar
• Horwitz C. A., Henle W., Henle G., Rudnick H., Latts E. Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J. Infect. Dis. 1985; 151(6)1150
   PubMed Web of Science ®Google Scholar
• Johnson D. R., Wolfe L. G., Levan G., Klein G., Ernberg I., Aman P. Epstein-Barr virus (EBV)-induced lymphoproliferative disease in cotton-topped marmosets. Int. J. Cancer 1983; 31: 91
   PubMed Web of Science ®Google Scholar
• Joncas J., Lapointe N., Gervais F., et al. Unusual prevalence of Epstein-Barr virus early antigen (EBV-EA) antibodies in ataxiatelangiectasia. J. Immunol. 1977; 119: 1857
   PubMed Web of Science ®Google Scholar
• Jondal M., Klein G. Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J. Exp. Med. 1973; 138: 1365
   PubMed Web of Science ®Google Scholar
• Jordan M. C., Jordan G. W., Stevens J. G., Miller G. Latent herpes viruses of humans. Ann. Intern Med. 1984; 100: 866
   PubMed Web of Science ®Google Scholar
• Kamaraju L. S., Levine P. H., Sundar S., et al. Epstein-Barr virus related lymphocyte stimulation inhibitor: a possible prognostic tool for undifferentiated nasopharyngeal carcinoma. J. Natl. Cancer Inst. 1983; 70(4)643
   PubMedGoogle Scholar
• Kaschka W. P., Klein G., Hilgers R., Skvaril F. Humoral immune response in Epstein-Barr virus infections. II. IgG subclass distribution in African patients with Burkitt's lymphoma and nasopharyngeal carcinoma. Clin. Exp. Immunol. 1984; 55: 14
   PubMed Web of Science ®Google Scholar
• Kieff E., Dambaugh T., Heller M., et al. The biology and chemistry of Epstein-Barr virus. J. Infect. Dis. 1982; 146(4)506
   PubMed Web of Science ®Google Scholar
• Kinlen L. J., Sheil A. G. R., Peto J., et al. Collaborative United Kingdom-Australian study of cancer in patients treated with immunosuppressive drugs. Br. Med. J. 1979; 2: 1461
   PubMed Web of Science ®Google Scholar
• Klein G. The Epstein-Barr virus and neoplasia. N. Engl. J. Med. 1975; 293: 1353
   PubMed Web of Science ®Google Scholar
• Klein G., et al. Cancer 1976; 21
   PubMedGoogle Scholar
• Klein G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 2442
   PubMed Web of Science ®Google Scholar
• Klein G. The relationship of the virus to nasopharyngeal carcinoma. The Epstein-Barr Virus, M. A. Epstein, B. G. Achong. Springer-Verlag, New York 1979; 340
   Google Scholar
• Klein G., Prutilo D. Summary: Symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients. Cancer Res. 1981; 41: 4302
   PubMed Web of Science ®Google Scholar
• Kottaridis S. D., Goula I., Kiparissiadis P. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma. Neoplasma 1982; 29(3)327
   PubMed Web of Science ®Google Scholar
• Krikorian J. G., Anderson J. L., Bieber C. P., et al. Malignant neoplasm following cardiac transplantations. JAMA 1978; 240: 639
   PubMed Web of Science ®Google Scholar
• Kunkle A., Klaus G. C. B. Selective effects of Cyclosporin A on functional B cell subsets in the mouse. J. Immunol. 1980; 125: 2526
   PubMed Web of Science ®Google Scholar
• Lanier A. P., Bornkamm G. W., Henle W., et al. Association of Epstein-Barr virus with nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA with DNA. Int. J. Cancer 1981; 28: 301
   PubMed Web of Science ®Google Scholar
• Lanier A. P., Henle W., Bender T. R., et al. Epstein-Barr virus-specific antibody titers in seven Alaskan natives before and after diagnosis of nasopharyngeal carcinoma. Int. J. Cancer 1980; 26: 133
   PubMed Web of Science ®Google Scholar
• Levine P. H., Ebbesen P., Connelly R. R. Complement-fixing antibody to Epstein-Barr virus soluble antigen in populations at high and low risk for nasopharyngeal carcinoma. Int. J. Cancer 1982; 29: 265
   PubMed Web of Science ®Google Scholar
• Levine P. H., Goepfert H., Neel H. B., et al. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC). Cancer Detect. Prevent. 1981; 4: 307
   PubMedGoogle Scholar
• Leyvraz S., Henle W., Chahinian A. P., Perlman C., Klein G., Gordon R. E., Rosenblum M., Holland J. F. Association of Epstein-Barr virus with thymic carcinoma. N. Engl. J. Med. 1985; 312: 1296
   PubMed Web of Science ®Google Scholar
• Lin J. C., Smith M. C., Cheng Y. C., Pagano J. S. Epstein-Barr virus: inhibition of replication by three new drugs. Science 1983; 221: 578
   PubMed Web of Science ®Google Scholar
• Lynn T. C., Hsieh R. P., Chuang C. Y., et al. Epstein-Barr virus-associated antibodies and serum biochemistry in nasopharyngeal carcinoma. Laryngoscope 1984; 94: 1485
   PubMed Web of Science ®Google Scholar
• Magrath I., Henle W., Owor R., Olweny C. Antibodies to Epstein-Barr virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease. N. Engl. J. Med. 1975; 292(12)621
   PubMed Web of Science ®Google Scholar
• Magrath I., et al. Prognostic factors in Burkitt's lymphoma: importance of total tumor burden. Cancer 1980; 45: 1507
   PubMed Web of Science ®Google Scholar
• Mann R. B., Berard C. W. Burkitt's tumor: lessons from mice, monkeys, and man. Lancet 1979; 2: 84
   Web of Science ®Google Scholar
• Manolov G., Manolva Y. Marker band in one chromosome 14 from Burkitt lymphomas. Nature (London) 1972; 237: 33
   PubMed Web of Science ®Google Scholar
• Marker S. G., Ascher N. L., Kalis J. M., et al. Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients. Surgery 1979; 85: 433
   PubMed Web of Science ®Google Scholar
• Mazur E. M., Lovett D. H., Enriquez R. E., Breg W. R., Papac R. J. Angioimmunoblastic lymphadenopathy. Evolution to a Burkitt-like lymphoma. Am. J. Med. 1979; 67: 317
   PubMed Web of Science ®Google Scholar
• McCaw B. K., Hecht F., Harnden D. G., et al. Somatic rearrangement of chromosome 14 human lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 2071
   PubMed Web of Science ®Google Scholar
• McCaw B. K., Epstein A. K., Kaplan H. S., et al. Chromosome 14 translocation in Africa and North American Burkitt's lymphoma. Int. J. Cancer 1977; 19: 482
   PubMed Web of Science ®Google Scholar
• Melbye M., Ebbesen P., Levine P. H., Bennike T. Early primary infection and high Epstein-Barr virus antibody titers in Greeland Eskimos at high risk for nasopharyngeal carcinoma. Int. J. Cancer 1984; 34: 619
   PubMed Web of Science ®Google Scholar
• Miller G. Epstein-Barr virus. Immortalization and replication. N. Engl. J. Med. 1984; 310(19)1255
   PubMed Web of Science ®Google Scholar
• Morgan D. G., Miller G., Niederman J. C., Smith H. W., Dowaliby J. M. Site of Epstein-Barr virus replication in the oropharynx. Lancet 1979; 1154
   PubMed Web of Science ®Google Scholar
• Morgan D. G., Niederman J. C., Miller G., et al. Site of Epstein-Barr virus replication in the oropharynx. Lancet 1979; 1154
   PubMed Web of Science ®Google Scholar
• Morigaki T., Ito Y. Intervening effect of L-asorbic acid on Epstein-Barr virus activation in human lymphoblastoid cells and its comparison with the effect of retinoic acid. Cancer Lett. 1982; 15: 255
   PubMed Web of Science ®Google Scholar
• Moss D. J., Burrows S. R., Castilino D. J., Kane R. G., Pope J. H., Rickinson A. B., Alpers M. P., Heywood P. F. A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and non-edemic regions of Papua New Guinea. Int. J. Cancer 1983; 31: 727
   PubMed Web of Science ®Google Scholar
• Muir C. S. Nasopharyngeal cancer—a historical vignette. Cancer J. Clin. 1983; 33: 180
   PubMed Web of Science ®Google Scholar
• Nagington J. Cyclosporin A immunosuppression and Epstein-Barr antibody. Lancet 1981; 2: 196
   PubMed Web of Science ®Google Scholar
• Nagington J., Gray J. Cyclosporin A immunosuppression, Epstein-Barr antibody, and lymphoma. Lancet 1980; 1: 536
   PubMed Web of Science ®Google Scholar
• Neel H. B., Pearson G. R., Taylor W. F. Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups. Ann. Otol. Rhinol. Laryngol. 1985; 93: 477
   Web of Science ®Google Scholar
• Neel H. B., Pearson G. R., Weilands L. H., et al. Anti-EBV serologic tests for nasopharyngeal carcinoma. Laryngoscope 1980; 90: 1981
   PubMed Web of Science ®Google Scholar
• Neel H. S., Pearson G. R., Weiland L. A., et al. Application of Epstein-Barr virus serology to the diagnosis and staging of North American patients with nasopharyngeal carcinoma. Otolaryngol. Head Neck Surg. 1983; 91: 255
   PubMed Web of Science ®Google Scholar
• Nidoskelainen J., et al. Epstein-Barr virus-specific serum immunoglobulin A as an acute phase antibody in infectious mononucleosis. J. Clin. Microbiol. 1979; 10: 75
   PubMed Web of Science ®Google Scholar
• Nielsein N. H., Mikkelsen F., Hansen J. P. H. Nasopharyngeal cancer in Greenland. The incidence in artic Eskimo population. Acta. Pathol. Microbiol. Scand. Sect. A 1977; 85: 850
   PubMedGoogle Scholar
• Nilsson K., Giovanella B. C., Shehlin J. S., et al. Tumorigenicity of human haematopoietic cell lines in athymic nude mice. Int. J. Cancer 1977; 19: 337
   PubMed Web of Science ®Google Scholar
• North J. R., Morgan A. J., Epstein M. A. Observations on the EB virus envelope and virus determined membrane antigen polypeptides. Int. J. Cancer 1980; 26: 231
   PubMed Web of Science ®Google Scholar
• Nowell P., Finan J., Erikson J., Croce C. Chromosome translocations, oncogene activation, and B-cell lymphomas. Normal and Neoplastic Hematopoiesis, D. W. Golde, P. A. Marks. Alan R. Liss, New York 1983; 31
   Google Scholar
• Oberender H., Nowak R., Donner A., et al. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups. Acta Virol. 1983; 27: 277
   PubMed Web of Science ®Google Scholar
• Old L. J., Boyse E. A., Ottegen H. F., et al. Precipitating antibody in human serum to antigen present in cultured Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. U.S.A. 1966; 56: 1699
   PubMed Web of Science ®Google Scholar
• Pagano J. S., Lemon S. M. The Herpes Viruses. Medical Microbiology and Infectious Diseases, A. I. Braude, C. E. Davis, J. Fierer. W. B. Saunders, Philadelphia 1981; 545
   Google Scholar
• Patel P. C., Dorval G., Menenzes J. Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines. Infect. Immun. 1982; 38: 251
   PubMed Web of Science ®Google Scholar
• Pattengale P. D., Taylor C. R., Pegalow C. Malignant B-cell lymphoma following and associated with infectious mononucleosis. A comparison of two cases. Am. J. Pediatr. Hematol. Oncol. 1981; 3: 35
   PubMedGoogle Scholar
• Pearson G. R., Neel H. B., III, Weiland L. H., et al. Antibody-dependent cellular cytotoxicity and disease course in North American patients with nasopharyngeal carcinoma: a prospective study. Int. J. Cancer 1984; 33: 777
   PubMed Web of Science ®Google Scholar
• Pena I. Malignant lymphomas in organ transplant recipients. Transplant, Proc. 1981; 13: 736
   PubMed Web of Science ®Google Scholar
• Purtilo D. T. Biology of disease. Defective immune surveillance in viral carcinogenesis. Lab. Invest. 1984; 51: 373
   PubMed Web of Science ®Google Scholar
• Purtilo D. T. Epstein-Barr-virus-induced oncogenesis in immune deficient individuals. Lancet 1980; 1: 300
   PubMed Web of Science ®Google Scholar
• Purtilo D. T., Cassell C., Yang J. P. S., et al. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975; 1: 935
   PubMed Web of Science ®Google Scholar
• Purtilo D. T., Sakamoto K., Barnabei V., Seeley J., Bechtold T., Rogers G., Yetz J., Harada S., the XLP Collaborators. Epstein-Barr virus-induced diseases in boys with X-linked lympho-proliferative syndrome (XPL). Update on studies of the registry. Am. J. Med. 1982; 73: 49
   PubMed Web of Science ®Google Scholar
• Raab-Traub N., Hood R., Yang C. S., et al. Epstein-Barr virus transcriptions in nasopharyngeal carcinoma. J. Virol. 1983; 48(3)580
   PubMed Web of Science ®Google Scholar
• Reece E. R., Gartner J. G., Seemayer T. A., Joncas J. H., Pagano J. S. Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency. Cancer Res. 1981; 41: 4243
   PubMed Web of Science ®Google Scholar
• Richtsmeier W. J. The interferons: present and future prospects. CRC Crit. Rev. Clin. Lab. Sci. 1984; 20: 57
   Web of Science ®Google Scholar
• Rickinson A. Epstein-Barr virus in epithelium. Nature (London) 1984; 310: 99
   PubMed Web of Science ®Google Scholar
• Ringborg J., Henle W., Henle G., et al. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck. Cancer 1983; 52(7)1237
   PubMed Web of Science ®Google Scholar
• Robinson J. E., Brown N., Andiman W., et al. Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus. N. Engl. J. Med. 1980; 302: 1293
   PubMed Web of Science ®Google Scholar
• Rooney C. M., Rickinson A. B., Moss D. J., Lenoir G. M., Epstein M. A. Cell-mediated surveillance mechanisms and the pathogenesis of Burkitt's lymphoma. Burkitt's Lymphoma: A Human Cancer Model, G. Lenoir, G. O'Connor, C. Olweny. IARC Scientific, Geneva 1984
   Google Scholar
• Rosenberg S. A., Lotze M. T., Muul L. M., et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-1. N. Engl. J. Med. 1985; 313: 1485
   PubMed Web of Science ®Google Scholar
• Saemundsen A. K., Albeck H., Hansen J. P. H., et al. Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimos. Br. J. Cancer 1982; 46: 721
   PubMed Web of Science ®Google Scholar
• Saemundsen A. K., Berkel A. I., Henle W., et al. Epstein-Barr virus-carrying lymphoma in a patient with ataxia-telangiectasia. Br. Med. J. 1981; 282: 425
   PubMed Web of Science ®Google Scholar
• Sakamoto K., Freed H., Purtilo D. T. Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome. J. Immunol. 1980; 125: 921
   PubMed Web of Science ®Google Scholar
• Sakamoto K., Seeley J. K., Lindsten T., Sexton J., Yetz J., Ballow M., Purtilo D. T. Abnormal anti-Epstein-Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk. J. Immunol. 1982; 128: 904
   PubMed Web of Science ®Google Scholar
• Schwartz R. S. Epstein-Barr virus—oncogen or mitogen?. N. Engl. J. Med. 1980; 302(23)1307
   PubMed Web of Science ®Google Scholar
• Seeley J., Sakamoto K., Ip S. H., Hansen P. W., Purtilo D. T. Abnormal lymphocyte subsets in X-linked lymphoproliferative syndrome. J. Immunol. 1981; 127: 2618
   PubMed Web of Science ®Google Scholar
• Shope T., Dechario D., Miller G. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc. Natl. Acad. Sci. U.S.A. 1973; 70: 2487
   PubMed Web of Science ®Google Scholar
• Sixby J. W., Nedrud J. G., Raab-Traub N., et al. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 1984; 310: 1225
   PubMed Web of Science ®Google Scholar
• Spriggs D. R. Cofactors in diseases: Epstein-Barr virus, oncogenes, and Burkitt's lymphoma. J. Infect. Dis. 1985; 151(5)977
   PubMed Web of Science ®Google Scholar
• Sullivan J. L., Medveckzky P., Forman S. J., et al. Epstein-Barr virus-induced lymphoproliferation. N. Engl. J. Med. 1984; 311: 1163
   PubMed Web of Science ®Google Scholar
• Sullivan J. L., Byron K., Brewster F., Purtilo D. T. Deficient natural killer cell activity in X-linked lymphoproliferative syndrome. Science 1980; 210: 543
   PubMed Web of Science ®Google Scholar
• Sullivan J. L., Sakamoto K., Buryn K. S., Brewster F. E., Purilo D. T. Prospective immunological and virological studies in a fatal case of the X-linked lymphoproliferative syndrome (XLP). Clin. Res. 1980; 28: 641A
   Google Scholar
• Sumaya C. V. Serological testing for Epstein-Barr virus—developments in interpretation. J. Infect. Dis. 1985; 151(6)984
   PubMed Web of Science ®Google Scholar
• Snydman D. R., Rudders R. A., Daoust P., Sullivan J. L., Evans A. S. Infectious mononucleosis in an adult progressing to fatal immunoblastic lymphoma. Ann. Intern Med. 1982; 96: 737
   PubMed Web of Science ®Google Scholar
• Spector B. D., Perry G. S., Kersey J. H. Genetically determined immunodeficiency diseases (GGID) and malignancy: report from the Immunodeficiency-Cancer Registry. Clin. Immunol. Immunopathol. 1978; 11: 12
   PubMedGoogle Scholar
• Starzl T. E., Klintmalm G. B. G., Weil R., et al. Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg. Gynecol. Obstet. 1981; 153: 486
   PubMedGoogle Scholar
• Strauch B., Andrews L., Siegel N., et al. Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive durgs. Lancet 1974; 1: 234
   PubMed Web of Science ®Google Scholar
• Sumaya C. V., Ench Y., Pope R. M. Improved test for IgM antibody to Epstein-Barr virus using an absorption step with Staphylococcus aureus. J. Infect. Dis. 1982; 146(4)518
   PubMed Web of Science ®Google Scholar
• Szigeti R., Saemundsen A. K., Synnerholm A-C., Henle G., Henle W., Klein G. Epstein-Barr virus-specific leukocyte migration inhibition reaction with tumor biopsy extracts: correlation with the presence of viral DNA. Cancer Res. 1983; 43: 2273
   PubMed Web of Science ®Google Scholar
• Takimoto T., Fururkawa M., Morishita K., et al. Nasopharyngeal carcinoma in Japan—clinical evaluation of EBV serology and EBV-associated nuclear antigens test. Auris. Nasus. Larynx (Tokyo) 1982; 9: 151
   PubMedGoogle Scholar
• Takimoto T., Kamide M., Umeda R. Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive. Nasopharyngeal carcinoma hybrid cell line (NPC-KT). Arch. Otorhinolaryngol. 1984; 239: 87
   PubMedGoogle Scholar
• Takimoto T., Morishita K., Furukawa M., et al. Establishment of Epstein-Barr virus (EBV) infection in epithelial cells derived from the nasopharynx by cell fusion. J. Laryngol. Otol. 1983; 97: 719
   PubMed Web of Science ®Google Scholar
• Takimoto T., Morishita K., Umeda R., et al. Infection of human epithelial cell lines by Epstein-Barr virus. Interaction between epithelial cell and B lymphocyte. ORL J. Otorhinologigal. Relat. Spec. 1984; 46: 195
   PubMedGoogle Scholar
• Takimoto T., Umeda R., Ogura H., Hatano M. Epstein-Barr virus activation of human epithelial-nasopharyngeal carcinoma hybrid cells. Am. J. Otol. 1984; 5: 1
   Google Scholar
• Tamada A., Makimoto K., Yamambe H., et al. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan. Cancer 1984; 53: 430
   PubMed Web of Science ®Google Scholar
• Tan R. S., Cheng Y. C., Naegele R. F., et al. Antibody responses to Epstein-Barr virus-specific DNAse in relation to the prognosis of juvenile patients with nasopharyngeal carcinoma. Int. J. Cancer 1982; 30: 561
   PubMed Web of Science ®Google Scholar
• Thomas J. A., Iliescu V., Crawford D. H., et al. Expression of HLA-DR antigens in nasopharyngeal carcinoma: an immunohistological analysis of the tumour cells and infiltrating lymphocytes. Int. J. Cancer 1984; 33: 813
   PubMed Web of Science ®Google Scholar
• Thompson J. L., Epstein M. A., Achong B. G., Chen J. J. A culture method giving substantial yields of normal nasopharyngeal epithelial cells for work with Epstein-Barr virus. J. Virol. Methods 1983; 6: 319
   PubMed Web of Science ®Google Scholar
• Tischendorf P., Schramek G. J., Balagtas R. C., et al. Development and persistence of immunity to Epstein-Barr virus in man. J. Infect. Dis. 1970; 122: 401
   PubMed Web of Science ®Google Scholar
• Tosato G., Magrath I. T., Blaese R. M. T cell-mediated immunoregulation of Epstein-Barr virus (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. J. Immunol. 1982; 128(2)575
   PubMed Web of Science ®Google Scholar
• Vonka V., Sibl O., Suchankova A., et al. Epstein-Barr virus antibodies in tonsillar carcinoma patients. Int. J. Cancer 1977; 19: 456
   PubMed Web of Science ®Google Scholar
• Wasik M., Myc A., Matej H., Rudzka L. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells. Arch. Immunol. Ther. Exp. (Warsz) 1983; 31(6)871
   PubMed Web of Science ®Google Scholar
• Wells C. Two mediaeval cases of malignant disease. Br. Med. J. 1964; 1: 1611
   PubMedGoogle Scholar
• Wells C. Ancient Egyptial pathology. J. Laryngol. Otol. 1963; 77: 261
   Google Scholar
• Wolf H. Epstein-Barr virus and carcinoma. Nature (London) 1984; 312: 705
   PubMed Web of Science ®Google Scholar
• Wolf H., Haus M., Wilmes E. Persistence of Epstein-Barr virus in the parotid gland. J. Virol. 1984; 51(3)795
   PubMed Web of Science ®Google Scholar
• Wolf H., Seibl R. Benign and malignant disease caused by EBV. J. Invest. Dermatol. 1984; 83(Suppl. 1)88
   PubMed Web of Science ®Google Scholar
• Wolf H., ZurHausen H., Vecker Y. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature (London) New Biol. 1973; 344: 245
   Google Scholar
• Yamamoto N., Matsumoto T., Koyanagi Y., et al. Unique cell lines harbouring both Epstein-Barr virus and adult T-cell leukaemia virus, established from leukaemia patients. Nature (London) 1982; 299: 367
   PubMed Web of Science ®Google Scholar
• Zech L., Haglund U., Nilsson K., et al. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int. J. Cancer 1976; 17: 47
   PubMed Web of Science ®Google Scholar
• Zeng Y., Gong C. H., Jan M. G., et al. Detection of Epstein-Barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immunoautoradiography. Int. J. Cancer 1983; 31: 599
   PubMed Web of Science ®Google Scholar
• Zeng Y., Miao X. C., Jaio B., et al. Epstein-Barr virus activation in Raji cells with ether extracts of soil from different areas in China. Cancer Lett. 1984; 23: 53
   PubMed Web of Science ®Google Scholar
• Ziegels-Weissman J., Nadjii M., Penneys N. S., Morales A. Prekaratin immunohistochemistry in the diagnosis of undifferentiated carcinoma of the nasopharyngeal type. Arch. Pathol. Lab. Med. 1984; 108: 588
   PubMed Web of Science ®Google Scholar
• Ziegler J. L. Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. N. Engl. J. Med. 1977; 297
   Web of Science ®Google Scholar
• Ziegler J. L., et al. Epstein-Barr virus and human malignancy. Ann. Intern Med. 1977; 296: 132
   Google Scholar
• Zimmerman M. R., Trinkaus E., LeMay M., Aufderheide A. C., et al. The paleopathology of an Aleutian mummy. Arch. Pathol. Lab. Med. 1981; 105: 638
   PubMed Web of Science ®Google Scholar
• ZurHausen H., Schulte-Holthausen H., Klein G., et al. EBV DNA in biopsies of Burkitt's tumours and anaplastic carcinomas of the nasopharynx. Nature (London) 1970; 228: 1056
   PubMed Web of Science ®Google Scholar